The Hidden Flaw in Our Gold Standard: Why Randomized Controlled Trials Need Better maths

The Silent Error in Randomized Controlled Trials

Imagine a master chef meticulously selecting ingredients, only to weigh them on a broken scale. In the world of science, randomized controlled trials act as this master kitchen, yet a preliminary study suggests our scales are failing us. For decades, we have relied on these trials to tell us which medicines work and which educational policies fail, assuming the 'sum score'—a simple tally of results—accurately reflects reality.

A Crisis of Measurement

Researchers recently analysed item-level data from 112 outcome measures across medicine, psychology, and education. This early-stage research, currently awaiting peer review, found that nearly half of these measures used scoring methods that did not plausibly represent the data. These foundational assumptions are rarely checked, creating a hidden layer of uncertainty in how we interpret human progress.

The Power of Precision

The findings suggest a startling shift:

• Standard sum scores often mask true treatment effects.
• Using statistical models aligned with study design doubled the number of significant results in pre/post trials.
• Measurement flexibility may be a primary driver behind the current replication crisis.

By refining how we organise and calculate these scores, scientists could recover lost insights. This research indicates that the 'gold standard' is not a fixed monument but a tool that requires constant recalibration to ensure the truth remains visible.